The status of epidermal growth factor receptor and topoisomerase IIα genes in triple-negative breast cancer cells
The paper gives the results of studying the genes of epidermal growth factor receptor (EGFR) and topoisomerase IIα (TOP IIα) in patients with triple-negative breast cancer (BC). It is suggested that the lack of EGFR gene amplification might serve as a factor of good prognosis. TOP IIα gene amplifica...
Saved in:
Main Authors: | D. A. Karseladze, I. V. Poddubnaya, A. I. Karseladze |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-08-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/266 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients
by: N. N. Babyshkina, et al.
Published: (2020-04-01) -
Diagnostic utility of ultrasound features in identifying triple-negative breast cancer
by: Jampana Sahitya, et al.
Published: (2025-05-01) -
α9 Nicotinic Acetylcholine Receptor Promotes Tumor Proliferation and Suppresses Ferroptosis in Triple-Negative Breast Cancer
by: Xiaoli Feng, et al.
Published: (2025-06-01) -
Role of Glucocorticoid Receptor in Triple-Negative Breast Cancer
by: Raj Kumar
Published: (2025-04-01) -
PROSPECTS FOR SEARCHING MULTITARGET TOPOISOMERASE INHIBITORS WITH ANTITUMOR PROPERTIES
by: M. I. Treshchalin, et al.
Published: (2019-09-01)